DocuSign (DOCU) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.

The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this provider of electronic signature technology, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- is principally built on this insight.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For DocuSign, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

Current-Quarter Estimate Revisions

The company is expected to earn $0.84 per share for the current quarter, which represents a year-over-year change of +10.53%.

Over the last 30 days, three estimates have moved higher for DocuSign while two have gone lower. As a result, the Zacks Consensus Estimate has increased 24.75%.

Current-Year Estimate Revisions

For the full year, the earnings estimate of $3.52 per share represents a change of +18.12% from the year-ago number.

There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, seven estimates have moved up for DocuSign versus no negative revisions. This has pushed the consensus estimate 11.39% higher.

Favorable Zacks Rank

The promising estimate revisions have helped DocuSign earn a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

DocuSign shares have added 16.2% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects.